Cynata Therapeutics Limited Stock Probability of Future Pink Sheet Price Finishing Over 0.4
| CYYNF Stock | USD 0.11 0.00 0.00% |
Cynata |
Cynata Therapeutics Target Price Odds to finish over 0.4
The tendency of Cynata Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 0.40 or more in 90 days |
| 0.11 | 90 days | 0.40 | close to zero percent |
Based on a normal probability distribution, the odds of Cynata Therapeutics to move over $ 0.40 or more in 90 days from now is close to zero percent (This Cynata Therapeutics Limited probability density function shows the probability of Cynata Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Cynata Therapeutics price to stay between its current price of $ 0.11 and $ 0.40 at the end of the 90-day period is about 1.78 .
Assuming the 90 days horizon Cynata Therapeutics Limited has a beta of -2.15 suggesting as returns on its benchmark rise, returns on holding Cynata Therapeutics Limited are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Cynata Therapeutics is expected to outperform its benchmark. Additionally Cynata Therapeutics Limited has an alpha of 0.9515, implying that it can generate a 0.95 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Cynata Therapeutics Price Density |
| Price |
Predictive Modules for Cynata Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cynata Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cynata Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cynata Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cynata Therapeutics is not an exception. The market had few large corrections towards the Cynata Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cynata Therapeutics Limited, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cynata Therapeutics within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 0.95 | |
β | Beta against NYSE Composite | -2.15 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.11 |
Cynata Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cynata Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cynata Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cynata Therapeutics is way too risky over 90 days horizon | |
| Cynata Therapeutics has some characteristics of a very speculative penny stock | |
| Cynata Therapeutics appears to be risky and price may revert if volatility continues | |
| Cynata Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 7.77 M. Net Loss for the year was (5.45 M) with profit before overhead, payroll, taxes, and interest of 7.77 M. | |
| Cynata Therapeutics Limited has accumulated about 26.79 M in cash with (3.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 15.0% of the company shares are held by company insiders |
Cynata Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cynata Pink Sheet often depends not only on the future outlook of the current and potential Cynata Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cynata Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 143.3 M |
Cynata Therapeutics Technical Analysis
Cynata Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Cynata Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cynata Therapeutics Limited. In general, you should focus on analyzing Cynata Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Cynata Therapeutics Predictive Forecast Models
Cynata Therapeutics' time-series forecasting models is one of many Cynata Therapeutics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cynata Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Cynata Therapeutics
Checking the ongoing alerts about Cynata Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cynata Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Cynata Therapeutics is way too risky over 90 days horizon | |
| Cynata Therapeutics has some characteristics of a very speculative penny stock | |
| Cynata Therapeutics appears to be risky and price may revert if volatility continues | |
| Cynata Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 7.77 M. Net Loss for the year was (5.45 M) with profit before overhead, payroll, taxes, and interest of 7.77 M. | |
| Cynata Therapeutics Limited has accumulated about 26.79 M in cash with (3.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 15.0% of the company shares are held by company insiders |
Check out Cynata Therapeutics Backtesting, Cynata Therapeutics Valuation, Cynata Therapeutics Correlation, Cynata Therapeutics Hype Analysis, Cynata Therapeutics Volatility, Cynata Therapeutics History as well as Cynata Therapeutics Performance. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Cynata Pink Sheet analysis
When running Cynata Therapeutics' price analysis, check to measure Cynata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cynata Therapeutics is operating at the current time. Most of Cynata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cynata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cynata Therapeutics' price. Additionally, you may evaluate how the addition of Cynata Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets |